These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7323743)

  • 21. [Effect of prostaglandin F2 on the bladder muscles in women].
    Gaudenz R
    Fortschr Med; 1980 Sep; 98(36):1387-90. PubMed ID: 7461547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurogenic failures of the external urethral sphincter closure and relaxation; a videourodynamic study.
    Sakakibara R; Hattori T; Uchiyama T; Yamanishi T; Ito H; Ito K
    Auton Neurosci; 2001 Jan; 86(3):208-15. PubMed ID: 11270099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prazosin in hypertension. Part I. Clinical experience in 100 patients.
    Turner AS; Watson OF; Brocklehurst JE
    N Z Med J; 1977 Sep; 86(596):282-5. PubMed ID: 24193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urodynamic studies in evaluating detrusor sphincter dyssynergia and their effects on the treatment.
    Buczyński AZ
    Paraplegia; 1984 Jun; 22(3):168-72. PubMed ID: 6540434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 26. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report.
    Gallego J; Forner V; Jimenez F; Martinez E
    Paraplegia; 1984 Aug; 22(4):216-24. PubMed ID: 6483464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term alpha-adrenergic-blocking therapy in detrusor-urethra dyssynergia.
    Vereecken RL; Van Poppel H; Boeckx G; Leruitte A
    Eur Urol; 1983; 9(3):167-9. PubMed ID: 6134620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia.
    Chartier-Kastler EJ; Ruud Bosch JL; Perrigot M; Chancellor MB; Richard F; Denys P
    J Urol; 2000 Nov; 164(5):1476-80. PubMed ID: 11025686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial].
    Goto M; Kato K; Kondo A; Otani T; Takita T; Kobayashi M
    Hinyokika Kiyo; 1988 Mar; 34(3):541-50. PubMed ID: 3389295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).
    Cruz F; Nitti V
    Neurourol Urodyn; 2014 Jul; 33 Suppl 3():S26-31. PubMed ID: 25042140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prazosin alone and combined with a beta-adrenoreceptor blocker in treatment of hypertension.
    Gould BA; Hornung RS; Kieso HA; Cashman PM; Raftery EB
    J Cardiovasc Pharmacol; 1983; 5(4):678-84. PubMed ID: 6193367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The syndrome of detrusor-sphincter dyssynergia.
    Andersen JT; Bradley WE
    J Urol; 1976 Oct; 116(4):493-5. PubMed ID: 1053342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenoxybenzamine in the management of neuropathic bladder following spinal cord injury.
    Al-Ali M; Salman G; Rasheed A; Al-Ani G; Al-Rubaiy S; Alwan A; Al-Shaikli A
    Aust N Z J Surg; 1999 Sep; 69(9):660-3. PubMed ID: 10515340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies of the effect of mictonorm (propiverin hydrochloride) and Spasuret (flavoxate hydrochloride) on the bladder detrusor muscle].
    Wehnert J; Sage S
    Z Urol Nephrol; 1989 May; 82(5):259-63. PubMed ID: 2665385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin.
    Gallien P; Robineau S; Verin M; Le Bot MP; Nicolas B; Brissot R
    Arch Phys Med Rehabil; 1998 Jun; 79(6):715-7. PubMed ID: 9630155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity.
    Mattiasson A; Ekström B; Andersson KE
    J Urol; 1989 Jan; 141(1):174-7. PubMed ID: 2908945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.